desipramine has been researched along with dihydromorphine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Albouz, S; Baumann, N; Bourdon, R; Boutry, JM; Hauw, JJ; Le Saux, F; Tocqué, B | 1 |
| Albouz, S; Baumann, N; Bourdon, R; Boutry, JM; Hauw, JJ; Le Saux, F; Tocque, B; Zalc, B | 1 |
3 other study(ies) available for desipramine and dihydromorphine
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Tricyclic antidepressant desipramine induces stereospecific opiate binding and lipid modifications in rat glioma C6 cells.
Topics: Animals; Cell Transformation, Neoplastic; Desipramine; Dihydromorphine; Glioma; Lipid Metabolism; Neuroblastoma; Rats; Receptors, Opioid; Stereoisomerism | 1982 |
Desipramine elicits the expression of opiate receptors and sulfogalactosylceramide synthesis in rat C6 glioma cells.
Topics: Animals; Cerebrosides; Desipramine; Dihydromorphine; Fluorescent Antibody Technique; Galactosylceramides; Glioma; Kinetics; Receptors, Opioid; Time Factors | 1984 |